Section Arrow
PYPD.NASDAQ
- PolyPid Ltd
Quotes are at least 15-min delayed:2025/07/22 02:28 EDT
Regular Hours
Last
 3.75
+0.13 (+3.59%)
Day High 
3.8 
Prev. Close
3.62 
1-M High
3.87 
Volume 
119.01K 
Bid
3.6
Ask
3.77
Day Low
3.61 
Open
3.63 
1-M Low
3.12 
Market Cap 
36.89M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 3.53 
20-SMA 3.54 
50-SMA 3.22 
52-W High 4.42 
52-W Low 2.3 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.24/-0.80
Enterprise Value
38.80M
Balance Sheet
Book Value Per Share
0.01
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TNFATNF Pharmaceuticals Inc.0.1294+0.0419+47.89%-- 
NCNANuCana plc0.051+0.0033+6.92%-- 
PMNProMIS Neurosciences1.12+0.6799+154.49%5PE
SABSSAB Biotherapeutics2.7+0.13+5.06%-- 
RXRXRecursion Pharmaceuticals6.4+0.56+9.59%-- 
Quotes are at least 15-min delayed:2025/07/22 02:28 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.